141 related articles for article (PubMed ID: 22627646)
21. Second primary cancers in subsites of colon and rectum in patients with previous colorectal cancer.
Liu L; Lemmens VE; De Hingh IH; de Vries E; Roukema JA; van Leerdam ME; Coebergh JW; Soerjomataram I
Dis Colon Rectum; 2013 Feb; 56(2):158-68. PubMed ID: 23303143
[TBL] [Abstract][Full Text] [Related]
22. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers.
Shiels MS; Gibson T; Sampson J; Albanes D; Andreotti G; Beane Freeman L; Berrington de Gonzalez A; Caporaso N; Curtis RE; Elena J; Freedman ND; Robien K; Black A; Morton LM
J Clin Oncol; 2014 Dec; 32(35):3989-95. PubMed ID: 25385740
[TBL] [Abstract][Full Text] [Related]
23. [Second primary lung cancer in laryngeal cancer patients: report on 36 cases].
Gao Y; Wang L; Zhang D
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):341-3. PubMed ID: 11783123
[TBL] [Abstract][Full Text] [Related]
24. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy.
Kawaguchi T; Matsumura A; Iuchi K; Ishikawa S; Maeda H; Fukai S; Komatsu H; Kawahara M
Jpn J Clin Oncol; 2006 Jan; 36(1):7-11. PubMed ID: 16368713
[TBL] [Abstract][Full Text] [Related]
25. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035
[TBL] [Abstract][Full Text] [Related]
26. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract][Full Text] [Related]
27. [Second primary cancers occurring in patients with cancers of the mouth and meso-hypo pharynx in Japan].
Kinoshita N; Koyama Y; Yoshino K; Tanaka H; Ajiki W; Tukuma H; Oshima A
Nihon Koshu Eisei Zasshi; 1997 Mar; 44(3):201-6. PubMed ID: 9175411
[TBL] [Abstract][Full Text] [Related]
28. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
Hamilton SN; Tyldesley S; Li D; Olson R; McBride M
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):977-85. PubMed ID: 25832690
[TBL] [Abstract][Full Text] [Related]
29. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
30. Salivary gland cancer in the United States.
Sun EC; Curtis R; Melbye M; Goedert JJ
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1095-100. PubMed ID: 10613342
[TBL] [Abstract][Full Text] [Related]
31. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
[TBL] [Abstract][Full Text] [Related]
32. High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.
Rusthoven KE; Flaig TW; Raben D; Kavanagh BD
Clin Lung Cancer; 2008 Mar; 9(2):106-11. PubMed ID: 18501097
[TBL] [Abstract][Full Text] [Related]
33. Lifetime risks of common cancers among retinoblastoma survivors.
Fletcher O; Easton D; Anderson K; Gilham C; Jay M; Peto J
J Natl Cancer Inst; 2004 Mar; 96(5):357-63. PubMed ID: 14996857
[TBL] [Abstract][Full Text] [Related]
34. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
35. Incidence of second primary cancers in three Italian population-based cancer registries.
Buiatti E; Crocetti E; Acciai S; Gafà L; Falcini F; Milandri C; La Rosa M
Eur J Cancer; 1997 Oct; 33(11):1829-34. PubMed ID: 9470841
[TBL] [Abstract][Full Text] [Related]
36. Increased risk of colon cancer after external radiation therapy for prostate cancer.
Rapiti E; Fioretta G; Verkooijen HM; Zanetti R; Schmidlin F; Shubert H; Merglen A; Miralbell R; Bouchardy C
Int J Cancer; 2008 Sep; 123(5):1141-5. PubMed ID: 18546265
[TBL] [Abstract][Full Text] [Related]
37. High incidence of independent second malignancies after non-muscle-invasive bladder cancer.
Zecha H; Schmid HP; Tschopp A; Sulser T; Engeler DS
Scand J Urol Nephrol; 2011 Sep; 45(4):245-50. PubMed ID: 21443417
[TBL] [Abstract][Full Text] [Related]
38. Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period.
Chen CY; Lai CH; Lee KD; Huang SH; Dai YM; Chen MC
Gynecol Oncol; 2012 Dec; 127(3):625-30. PubMed ID: 22975362
[TBL] [Abstract][Full Text] [Related]
39. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
40. Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
Khanal A; Budhathoki N; Singh VP; Shah BK
Anticancer Res; 2017 Apr; 37(4):2033-2036. PubMed ID: 28373478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]